A recent study by Plum Data Labs highlighted the healthcare insurance challenges faced by cancer patients in India. Analyzing a significant number of cancer claims filed between 2023 and 2025, the study revealed a concerning trend.
While India has shown improvement in early cancer detection, the healthcare system struggles to provide adequate financial support for patients undergoing advanced, multi-stage treatments. The data indicated a notable increase in stage 0 cancer cases, rising from 29% in early 2023 to nearly 50% by 2024, ultimately settling at 47% in early 2025. The rise in early-stage cancer diagnoses over the three-year period amounted to approximately 72%.
Despite the positive aspect of early detection, families still face significant financial burdens. The treatment process has evolved into a series of multiple claims for each patient, with some individuals filing up to four claims annually. For patients with advanced cancer, the number of claims can escalate to between 11 and 22 over several months, encompassing various treatments like surgery, chemotherapy rounds, targeted therapies, and other medical procedures.
This fragmented approach to treatment leads to delays and challenges for families as they navigate hospital schedules and insurance processes concurrently. The study also highlighted the escalating costs of cancer treatment based on detailed case studies. For instance, a 40-year-old man with head and neck cancer incurred expenses of Rs 42.44 lakh in just over two months, predominantly due to high-cost hospitalizations. Similarly, a 49-year-old woman with leukemia spent Rs 40.56 lakh in three and a half months.
The analysis across different cancer types revealed varying cumulative costs, with colorectal cancer ranking highest at around Rs 5.07 lakh on average. The financial burden extends to out-of-pocket expenses for patients, with brain cancer patients bearing costs exceeding Rs 2.62 lakh personally. Moreover, insurance payouts have decreased over time, with insurers covering around 63% of claim amounts by early 2025, down from 76% in early 2023.
The decline in insurance coverage can be attributed to policy limitations, including caps on modern treatments, co-pay clauses, and exclusions that restrict payouts. As cancer treatment advances with the introduction of modern therapies, insurance structures need to adapt to provide comprehensive coverage. Without significant changes in policy design to accommodate modern oncology practices and ensure realistic coverage levels, the financial burden of cancer treatment will remain a pressing issue for households in India.